Key Insights

Highlights

Treatment Research

4 treatments under study, led by Iodoformcalcium Hydroxide Metapex

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Iodoformcalcium Hydroxide Metapex1
  • Rotary Instrumentation1
  • Zinc Oxide Eugenol Zoe1
  • Manual Instrumentation1

Active Sponsors

  • October University for Modern Sciences and Arts1

Activity Timeline